ICICI Securities's research report on RBL Bank
We are enthused with RBL Bank’s (RBL) proposed transaction with Emirates NBD (ENBD) as it brings strong parentage to RBL, opens huge secular growth runway and solves frequent capital needs (pro forma CET 1 >35%). We highlight potential substantial dilution for existing shareholders. However, book value should remain broadly intact (FY27E ABV of ~INR 295 per share vs. proposed infusion at INR 280). We are mindful of sub-optimal pro forma RoE (due to low leverage) but believe that strong growth, superior balance sheet and an uptick in RoA could make risk-reward favourable. Our estimates do not factor in capital infusion yet.
Outlook
We upgrade RBL to BUY (vs. Hold); TP revised to INR 415 (vs. INR 250 earlier) based on ~1.4x FY27E ABV (~0.85x earlier). Key risks: Hiccups, if any, in deal consummation.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
